Matches in SemOpenAlex for { <https://semopenalex.org/work/W3118385613> ?p ?o ?g. }
- W3118385613 abstract "High-risk neuroblastoma (NB) is responsible for a disproportionate number of childhood deaths due to cancer. One indicator of high-risk NB is amplification of the neural MYC (MYCN) oncogene, which is currently therapeutically intractable. Identification of anaplastic lymphoma kinase (ALK) as an NB oncogene raised the possibility of using ALK tyrosine kinase inhibitors (TKIs) in treatment of patients with activating ALK mutations. 8-10% of primary NB patients are ALK-positive, a figure that increases in the relapsed population. ALK is activated by the ALKAL2 ligand located on chromosome 2p, along with ALK and MYCN, in the 2p-gain region associated with NB. Dysregulation of ALK ligand in NB has not been addressed, although one of the first oncogenes described was v-sis that shares > 90% homology with PDGF. Therefore, we tested whether ALKAL2 ligand could potentiate NB progression in the absence of ALK mutation. We show that ALKAL2 overexpression in mice drives ALK TKI-sensitive NB in the absence of ALK mutation, suggesting that additional NB patients, such as those exhibiting 2p-gain, may benefit from ALK TKI-based therapeutic intervention." @default.
- W3118385613 created "2021-01-18" @default.
- W3118385613 creator A5007977575 @default.
- W3118385613 creator A5017973457 @default.
- W3118385613 creator A5021044156 @default.
- W3118385613 creator A5022744068 @default.
- W3118385613 creator A5025880133 @default.
- W3118385613 creator A5032564835 @default.
- W3118385613 creator A5032696676 @default.
- W3118385613 creator A5034188188 @default.
- W3118385613 creator A5038426102 @default.
- W3118385613 creator A5042555918 @default.
- W3118385613 creator A5044229149 @default.
- W3118385613 creator A5053470723 @default.
- W3118385613 creator A5058614649 @default.
- W3118385613 creator A5060679093 @default.
- W3118385613 creator A5061098472 @default.
- W3118385613 creator A5082957078 @default.
- W3118385613 creator A5084020489 @default.
- W3118385613 creator A5088344698 @default.
- W3118385613 creator A5091191169 @default.
- W3118385613 date "2021-01-07" @default.
- W3118385613 modified "2023-10-16" @default.
- W3118385613 title "ALK ligand ALKAL2 potentiates MYCN‐driven neuroblastoma in the absence of <i>ALK</i> mutation" @default.
- W3118385613 cites W1502410692 @default.
- W3118385613 cites W190146143 @default.
- W3118385613 cites W1974837024 @default.
- W3118385613 cites W1975686452 @default.
- W3118385613 cites W1981714967 @default.
- W3118385613 cites W1982020713 @default.
- W3118385613 cites W1986522151 @default.
- W3118385613 cites W1987468541 @default.
- W3118385613 cites W1993428519 @default.
- W3118385613 cites W1994438989 @default.
- W3118385613 cites W2010978319 @default.
- W3118385613 cites W2012040948 @default.
- W3118385613 cites W2017083055 @default.
- W3118385613 cites W2021876472 @default.
- W3118385613 cites W2022354436 @default.
- W3118385613 cites W2025529909 @default.
- W3118385613 cites W2026002143 @default.
- W3118385613 cites W2028831927 @default.
- W3118385613 cites W2035282066 @default.
- W3118385613 cites W2037199116 @default.
- W3118385613 cites W2038586807 @default.
- W3118385613 cites W2038637004 @default.
- W3118385613 cites W2042752142 @default.
- W3118385613 cites W2044033792 @default.
- W3118385613 cites W2044558623 @default.
- W3118385613 cites W2060275730 @default.
- W3118385613 cites W2063337289 @default.
- W3118385613 cites W2067606868 @default.
- W3118385613 cites W2085324333 @default.
- W3118385613 cites W2096465161 @default.
- W3118385613 cites W2097417052 @default.
- W3118385613 cites W2102278945 @default.
- W3118385613 cites W2103600998 @default.
- W3118385613 cites W2110065044 @default.
- W3118385613 cites W2117131162 @default.
- W3118385613 cites W2120264635 @default.
- W3118385613 cites W2121647859 @default.
- W3118385613 cites W2124478432 @default.
- W3118385613 cites W2127193805 @default.
- W3118385613 cites W2130410032 @default.
- W3118385613 cites W2132546867 @default.
- W3118385613 cites W2134526812 @default.
- W3118385613 cites W2135581618 @default.
- W3118385613 cites W2146512944 @default.
- W3118385613 cites W2150850730 @default.
- W3118385613 cites W2151322893 @default.
- W3118385613 cites W2153947402 @default.
- W3118385613 cites W2155440541 @default.
- W3118385613 cites W2161954865 @default.
- W3118385613 cites W2166065779 @default.
- W3118385613 cites W2167279371 @default.
- W3118385613 cites W2175370850 @default.
- W3118385613 cites W2181333015 @default.
- W3118385613 cites W2191509812 @default.
- W3118385613 cites W2213548494 @default.
- W3118385613 cites W2235737683 @default.
- W3118385613 cites W2271679886 @default.
- W3118385613 cites W2287835706 @default.
- W3118385613 cites W2330978802 @default.
- W3118385613 cites W2462717932 @default.
- W3118385613 cites W2617446144 @default.
- W3118385613 cites W2742652175 @default.
- W3118385613 cites W2759314369 @default.
- W3118385613 cites W2766579658 @default.
- W3118385613 cites W2766627619 @default.
- W3118385613 cites W2789869568 @default.
- W3118385613 cites W2789924919 @default.
- W3118385613 cites W2796407886 @default.
- W3118385613 cites W2808103253 @default.
- W3118385613 cites W2900514529 @default.
- W3118385613 cites W2900564926 @default.
- W3118385613 cites W2911971642 @default.
- W3118385613 cites W2917516523 @default.
- W3118385613 cites W2922363031 @default.
- W3118385613 cites W2951128531 @default.
- W3118385613 cites W2952509678 @default.